GRB2 and hepatocellular carcinoma: Similar with GRB2, the disease-free survival (Figure 6C, P=0.006) and overall survival (Figure 6D, P=0.008) of HCC patients with high GAB1 expression were both significantly shorter than those with low GAB1 expression.